Astellas Pharma Inc
Clinical trials sponsored by Astellas Pharma Inc, explained in plain language.
-
Monthly eye injections tested for safety in japanese patients with blinding eye disease
Disease control Recruiting nowThis study is checking the safety and side effects of a monthly eye injection called ASP3021 for people in Japan with geographic atrophy, a late-stage form of age-related macular degeneration (AMD) that causes progressive vision loss. About 20 participants will receive the inject…
Phase: PHASE4 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
First-in-Human trial targets common Cancer-Causing gene
Disease control Recruiting nowThis is the first time researchers are giving the experimental drug ASP5834 to people. The study aims to find a safe dose and check for side effects in adults with advanced solid tumors that have specific changes in a gene called KRAS. Some participants with colorectal cancer wil…
Phase: PHASE1 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Massive study tracks safety of new arthritis drug
Disease control Recruiting nowThis study is monitoring the safety and effectiveness of the drug peficitinib in people with rheumatoid arthritis during routine medical care in Japan. It will enroll 3000 patients who are starting this medication for the first time. The goal is to understand how well the drug wo…
Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New drug targets 'Undruggable' cancer mutation in first human trial
Disease control Recruiting nowThis is a first-in-human study to find a safe dose of a new drug, ASP3082, for people with advanced solid tumors that have a specific genetic change called KRAS G12D. The study will test ASP3082 alone and in combination with other cancer drugs in up to 681 participants. The main …
Phase: PHASE1 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC